Ginsenoside Rd protects transgenic Caenorhabditis elegans from β-amyloid toxicity by activating oxidative resistant
Alzheimer’s disease (AD) is a serious public health issue but few drugs are currently available for the disease, and these only target the symptoms. It is well established that oxidative stress plays a crucial role in AD, and there is compelling evidence linking oxidative stress to β-amyloid (Aβ). A...
Main Authors: | Lihan Mi, Meiling Fan, Tianjia Liu, Donglu Wu, Yang Wang, Fuqiang Li, Yong Cai, Zhidong Qiu, Da Liu, Lingling Cao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1074397/full |
Similar Items
-
Ginsenosides Rg1 regulate lipid metabolism and temperature adaptation in Caenorhabditis elegans
by: Hao Shi, et al.
Published: (2023-07-01) -
Insights into Recent Studies on Biotransformation and Pharmacological Activities of Ginsenoside Rd
by: Xiaoping Song, et al.
Published: (2022-03-01) -
Ginsenoside Rd attenuated hyperglycemia via Akt pathway and modulated gut microbiota in streptozotocin-induced diabetic rats
by: Wei Wang, et al.
Published: (2023-01-01) -
Ginsenoside Rd promotes omentin secretion in adipose through TBK1-AMPK to improve mitochondrial biogenesis via WNT5A/Ca2+ pathways in heart failure
by: Shiyao Wan, et al.
Published: (2023-04-01) -
Ginsenoside Rd ameliorates muscle wasting by suppressing the signal transducer and activator of transcription 3 pathway
by: Yoseph Toni Wijaya, et al.
Published: (2022-12-01)